Tau drug heads into phase 3 trials in frontotemporal dementia, Alzheimer's
Friday, October 5, 2012 - 16:00
in Psychology & Sociology
A small company with roots in Singapore and Scotland plans to test a relatively unknown compound in clinical trials for a type of dementia that strongly affects behavior.